Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC May 15, 2026 07:08AM
Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC May 15, 2026 07:07AM
Form SCHEDULE 13G/A Andersen Group Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC May 15, 2026 07:04AM
Climb Bio raises $110 million in private placement Apr 28, 2026 07:00AM
Maze Therapeutics prices $150 million stock offering at $23.50 per share Apr 22, 2026 05:14AM
View Older Stories

Mar 16, 2026 07:03AM Alto Neuroscience raises $120 million in private placement financing
Mar 9, 2026 07:30AM Korro Bio raises $85 million in oversubscribed private placement
Feb 17, 2026 09:25AM Form SCHEDULE 13G PALATIN TECHNOLOGIES Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 17, 2026 09:22AM Form SCHEDULE 13G Definium Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 17, 2026 09:20AM Form SCHEDULE 13G Andersen Group Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 17, 2026 09:17AM Form SCHEDULE 13G/A Planet Labs PBC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 17, 2026 09:14AM Form SCHEDULE 13G/A Paymentus Holdings, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 17, 2026 09:08AM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jan 30, 2026 08:31AM ALX Oncology prices $150 million stock and warrant offering
Nov 14, 2025 08:57AM Form SCHEDULE 13G Planet Labs PBC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Nov 14, 2025 08:55AM Form SCHEDULE 13G/A Paymentus Holdings, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Nov 14, 2025 08:52AM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Nov 14, 2025 07:27AM Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Nov 14, 2025 07:24AM Form SCHEDULE 13G/A Solaris Energy Infrastru Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Nov 10, 2025 06:12PM Precision BioSciences raises $75 million in stock and warrant offering
Nov 4, 2025 07:10AM Relmada Therapeutics prices $100 million stock offering at $2.20 per share
Sep 11, 2025 07:35AM Maze Therapeutics raises $150 million in oversubscribed private placement
Sep 10, 2025 12:53PM Form SCHEDULE 13G/A Blue Foundry Bancorp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Aug 14, 2025 07:51AM Form SCHEDULE 13G/A Paymentus Holdings, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Aug 14, 2025 07:48AM Form SCHEDULE 13G/A Dynamix Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Aug 14, 2025 07:45AM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Aug 14, 2025 07:42AM Form SCHEDULE 13G/A QUINSTREET, INC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jun 10, 2025 10:55AM Form SCHEDULE 13G/A Septerna, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:36AM Form SCHEDULE 13G Surrozen, Inc./DE Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:33AM Form SCHEDULE 13G Solaris Energy Infrastru Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:28AM Form SCHEDULE 13G QUINSTREET, INC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:23AM Form SCHEDULE 13G Paymentus Holdings, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:21AM Form SCHEDULE 13G Dynamix Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 15, 2025 07:17AM Form SCHEDULE 13G/A Septerna, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Apr 2, 2025 06:23AM Edgewise Therapeutics Inc. (EWTX) Announces Pricing of $200M Underwritten Offering of Common Stock
Feb 14, 2025 07:52AM Form SCHEDULE 13G Korro Bio, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2025 07:49AM Form SCHEDULE 13G Septerna, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Dec 2, 2024 07:33AM Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
Nov 14, 2024 11:16AM Form SC 13G Apogee Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Oct 31, 2024 07:02AM Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement
Oct 29, 2024 07:02AM GlycoMimetics (GLYC) Enters Acquisition Agreement With Crescent Biopharma
Jun 10, 2024 09:08AM Form SC 13G/A Heritage Insurance Holdi Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jun 10, 2024 09:05AM Form SC 13G/A APPLIED OPTOELECTRONICS, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 30, 2024 07:37AM Celcuity (CELC) Pricies 3.87M Underwritten Common Stock Offering at $15.50/sh
May 30, 2024 07:36AM Celcuity Announces Pricing of Underwritten Common Stock Offering
May 2, 2024 07:31AM Context Therapeutics (CNTX) Announces $100 Million Private Placement
May 2, 2024 07:30AM Context Therapeutics Announces $100 Million Private Placement
Apr 3, 2024 07:51AM Cancer biotech firm Alterome Therapeutics raises $132 million in Goldman Sachs-led round
Apr 3, 2024 06:00AM Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Mar 7, 2024 07:15AM Mind Medicine (MNMD) Prices 16.67M Share Offering at $6/sh
Mar 7, 2024 07:13AM Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
Mar 4, 2024 04:10PM Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Feb 28, 2024 08:00AM Crinetics Pharmaceuticals (CRNX) Announces 8.33M Share Offering at $42/sh
Feb 28, 2024 08:00AM Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
Feb 14, 2024 08:05AM Form SC 13G Heritage Insurance Holdi Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
View Older Stories